This episode contains the following;
A look back at Japanese biotech that has not been able to push a single drug to phase 2 in 13 years, and an oil & gas company which pays their investor relations director over 700,000 $ or six times the average.
Tickers & Reports
Muddy Waters on Peptidream (4587.JP)
Culper Research on ProPetro (PUMP)Note: The IR salary of Sam Sledge is more like 6x than 7x just to be precise.

This episode contains the following; A look back at Japanese biotech that has not been able to push a single drug to phase 2 in 13 years, and an oil & gas company which pays their investor relations director over 700,000 $ or six times the average. Tickers & Reports Muddy Waters on Peptidream (4587.JP) Culper Research on ProPetro (PUMP)Note: The IR salary of Sam Sledge is more like 6x than 7x just to be precise.

This episode contains the following;
A look back at Japanese biotech that has not been able to push a single drug to phase 2 in 13 years, and an oil &amp; gas company which pays their investor relations director over 700,000 $ or six times the average.
Tickers &amp; Reports
Muddy Waters on Peptidream (4587.JP)
Culper Research on ProPetro (PUMP)Note: The IR salary of Sam Sledge is more like 6x than 7x just to be precise.

Episode #4 - Week 08.11

A weekly podcast about short selling. Want to know who is shorting what and why? Then subscribe.

Share Episode #4 - Week 08.11

Sign up to save your podcasts

Episode #4 - Week 08.11

Episode #4 - Week 08.11